CPhI Conference: Generics and Biosimilars Strategies EMEA

By Cphi Conferences, PRNE
Wednesday, June 8, 2011

LONDON, June 9, 2011 -

- Strengthening Your Global Position and Protecting Margins Through
Expansion, Innovation and Differentiation

- 27-28 September 2011, Istanbul, Turkey

- www.generics-emea.com

CPhI Conferences, part of the team responsible for CPhI Worldwide, is
hosting a new two-day conference for the international pharmaceutical
community offering business-focused insight on how to succeed in the generics
and biosimilars markets.

With it estimated that drugs worth nearly $25 billion in sales will come
off patent in 2011, interest in future opportunities for generics and
biosimilars are high. But with ongoing pricing pressures and the continuing
consolidation of the market, companies are looking to emerging markets,
differentiation strategies and innovations in super-generics and biosimilars
for future growth.

Given global interest in Turkey's booming generics market and its
position at the heart of EMEA, holding this event in Istanbul will provide a
valuable business and networking opportunity to delegates from across the

CPhI are delighted to be working in association with the Turkish
Pharmaceutical Manufacturers Association (IEIS). Mr. Nezih Barut, Chairman of
IEIS says: "I am sure attendees will not only make use of the new information
and networking possibilities that the conference will bring together, but
will also have the chance to explore what Istanbul has to offer to its
visitors. As the leading organisation in the Turkish pharmaceutical industry,
we consider this CPhI conference as an important event and therefore provide
our support"

CPhI Conferences will be bringing together an international panel of
expert speakers primarily representing big pharma, generics, biosimilars and
consultancy companies. Over the course of the two days they will be offering
delegates insights on strategy, business development, marketing, regulation,
innovation and more.

Uniquely, the afternoon of Day 2 will be dedicated to exploring the
challenges and opportunities presented by the Turkish market and examine the
pricing, legal, regulatory and business realities of operating there. For
those with an eye on Turkey's booming consumer market, it will be an
invaluable opportunity to meet key players.

Please visit www.generics-emea.com for more information and to see
the agenda.

Tickets for the conference are EUR1099 for the Full 2 day conference,
EUR399 for the Turkey Masterclass only and EUR275 for the Post-Conference
Workshop. Group booking discounts are available - please contact
+44(0)20-7921-8039 or conferences@ubm.com for additional information.

For further information, please contact: Amanda Hecht, Marketing Executive, UBM Conferences
Ludgate House, 245 Blackfriars Road, London, SE1 9UY, Tel: +44(0)20-7955-3833, Email: amanda.hecht at ubm.com

will not be displayed